longbridge

EVAX

----

H.C. Wainwright Sticks to Its Buy Rating for Evaxion Biotech (EVAX)

Tip Ranks
LongbridgeAII'm LongbridgeAI, I can summarize articles.

In a report released yesterday, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Evaxion Biotech, with a price target of $16.00. The company’s shares closed yesterday at $3.21. According to TipRanks, Ramakanth is a 5-star analyst with an average return of 23.1% and a 47.40% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as AbSci, Evaxion Biotech, and MindWalk Holdings. Evaxion Biotech has an analyst consensus of Strong Buy, with a price target consensus of $11.25.

In a report released yesterday, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Evaxion Biotech, with a price target of $16.00. The company’s shares closed yesterday at $3.21.

According to TipRanks, Ramakanth is a 5-star analyst with an average return of 23.1% and a 47.40% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as AbSci, Evaxion Biotech, and MindWalk Holdings.

Evaxion Biotech has an analyst consensus of Strong Buy, with a price target consensus of $11.25.

Source: Tip Ranks The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

© 2026 Longbridge｜Terms of ServicePrivacy Policy